Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_assertion type Assertion NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_head.
- NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_assertion description "[Further analyses of 64 cases of gliosarcoma using quantitative PCR showed amplification of the STOML3, FREM2, and LHFP genes in 14 (22%), 10 (16%), and 7 (11%) mesenchymal tumor areas, respectively, but not in glial tumor areas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_provenance.
- NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_assertion evidence source_evidence_literature NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_provenance.
- NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_assertion SIO_000772 22538188 NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_provenance.
- NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_assertion wasDerivedFrom befree-20150227 NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_provenance.
- NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_assertion wasGeneratedBy ECO_0000203 NP838012.RAFPpnx6q9wt7IyEuF4BlVrnRLTVwtBPCvhYSvvWAcSR8130_provenance.